Analyst Research Report Snapshot

Title:

Hindustan Unilever (HUVR) - Qtr. Update - Dated - October 26, 2012

Price:

$46.00

Provider:

Axis Capital Limited

Date:

27 Oct 2012

Pages:

5

Type:

AcrobatPDF

Companies referenced:

HLL.NS

Available for Immediate Download
Summary:

Hindustan Unilever Ltd (HUL) reported 5th consecutive quarter of 20%+ profit growth, largely driven by margin pull back in Soaps and Detergents segment. However, domestic volume growth of 7% was the lowest since FY10 due to de-stocking at Canteen Store Department (CSD) and softer demand in certain discretionary categories. The impact of below consensus volume growth was offset by higher than expected margin improvement to 15.5%. Growth momentum could slip  Domestic FMCG business grew 16% YoY in Q2FY13, predominantly led by 22% growth in Soaps and Detergent (S&D) segment. With softening commodity costs, unfavorable base effect kicking in, and no further price hikes, we expect S&D to deliver normalized revenue growth of 14% in Q4FY13.  Key headwinds to watch out for are extent of slowdown in personal care segment and further rationalization of CSD sales. Overall revenue to grow 15% in FY14E vs. 17% in FY13E. Margin levers intact, but earnings upgrades unlikely  From a trough of 13.7% in FY11, EBITDA margin at 15.6% in FY13E would revert to its mean. This is similar to 7 years peak in FY10, just before the detergent price war. Thus, a significant position of margin surprise is behind us.  Increase in tax rate and lower growth in other income (post special dividend) is expected to dampen earnings growth to 12% in FY14E, despite 19% growth in operating earnings. Trades above fair value; Maintain SELL  Our discounted cash flow (DCF) based TP of Rs 490 implies 15% revenue CAGR and 180 bps margin expansion led by increase in revenue contribution from Personal Care and continuing premiumization trend.  As the stock trades 11% above our fair value, we believe much of the fundamental upside is captured. In fact, HUL’s 1-yr forward P/E (Oct-13) at 36x is similar to Nestlé’s valuation, which is unjustified, given Nestlé’s latent growth potential and strong pricing power. Maintain SELL.  At CMP of Rs 552, the stock trades at 37x FY13E EPS of Rs 14.9 and 33x FY14E EPS of Rs 16.6. Regards, Hemant B Patel (Executive Director – Consumer) Institutional Equity Research Axis Capital Ltd Tel: + 91 22 4325 1105 Ajay Thakur (AVP – Consumer) Institutional Equity Research Axis Capital Ltd Tel: + 91 22 4325 1125

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.